Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
110.00    -3.00 (-2.65%)
Bid:
108.00
Ask:
112.00
Spread: 4.00 (3.704%)
Market Cap: £66.18m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

MyID within Intel Authenticate

1 Mar 2016 14:00

RNS Number : 6444Q
Intercede Group PLC
01 March 2016
 

 

 

PRESS RELEASE

 

Intercede Eliminates Passwords in the Workplace

 

New software from Intercede provides added protection using Intel® Authenticate for enterprise PCs

 

RSA CONFERENCE 2016, San Francisco, March 1, 2016 - Today, digital identity and credentials expert Intercede announced new security software designed for deployment alongside Intel's latest hardware-based identity protection technology, Intel® Authenticate. Intercede software, running on the 6th Gen Intel® Core™ vPro™ processor, works in combination with Intercede's MyID credentials management solution to replace password-based access control for networks, applications and services with certificate-based, highly secure and convenient hardware-backed protection.

 

Intel and Intercede have worked together to integrate Intercede's Minidriver and Virtual Reader software - a development of the company's core MyID platform - within Intel Authenticate. Available in preview, Intel Authenticate is a hardware-enhanced, multifactor authentication solution that strengthens identity protection on the PC, making it less vulnerable to identity breaches and security credential attacks. Intercede will complement Intel Authenticate by making hardware-backed credentials available for Windows and domain logon, as well as making credentials issuance and management simpler and more scalable.

 

Enterprise customers will now have the ability to utilize Intercede's MyID solution to easily issue and manage the credentials lifecycle. MyID was the first electronic personalization system to achieve FIPS 201 compliance in the U.S. and a leading and established choice for national governments and major companies in the aerospace and defense sector entrusted with protecting some of the world's most sensitive data. Enterprises will soon be able to use Intercede's high security technology with Intel Authenticate to remove the need for usernames and passwords and provide higher levels of user authentication.

 

"Intel Authenticate is a solid technology built to intelligently help secure Windows based platforms in today's enterprise environments," said Richard Parris CEO of Intercede. We are proud to be working with Intel to provide differentiating technology that works with their new generation solution. Intel Authenticate, coupled with MyID, enables end-user companies to focus on their business and to protect their workforce and assets with a more highly secure solution that is cost-effective, easy to deploy and manage across a global enterprise."

 

"We're excited to advance our work on Intel Authenticate, working with premier security companies like Intercede. Together, we're empowering enterprise to not only dramatically improve identity security, but to do so in a way that improves the ease of use and experience for the business professional," said Tom Garrison, vice president and general manager for the Intel Business Client Division.

 

To preview the new security technology first hand, demonstrations will be available during the RSA 16 conference in San Francisco. For more information at the show, stop by the Intel RSA 16 booth located at North Expo D3705.

 

 

Enquiries:

 

Intercede Group plc Tel: 01455 558111

Richard Parris, Chairman & Chief Executive

Andrew Walker, Finance Director

 

finnCap Ltd Tel: 020 7220 0500

Stuart Andrews, Corporate Finance

Joanna Scott, Corporate Broking

 

 

Notes to editors

 

MyID

For a credential to be trusted it needs to be managed, an organization needs to know that the right people have been issued the correct credentials, this is what MyID provides. The existing MyID platform has been enhanced to support issuance and management of Intel Authenticate® chip-protected credentials, allowing an organization to deploy and use them simply and at scale.

 

 

About Intercede

Intercede is a software and service company specializing in identity, credential management and secure mobility. Its solutions create a foundation of trust between connected people, devices and apps and combine expertise with innovation to provide world-class cybersecurity. Intercede has been delivering solutions to high profile customers, from the US and UK governments to some of the world's largest corporations, telecommunications providers and information technology firms, for over 20 years. Intercede's product portfolio includes MyID, an identity and credential management system that assigns trusted digital identities to employees citizens and machines. In 2015, Intercede launched MyTAM, enabling trusted applications to be loaded into a mobile device's Trusted Execution Environment (TEE), providing hardware-level security for Android apps.

 

For more information visit: www.intercede.com or follow us on Twitter: @IntercedeMyID

 

Intel and Intel Authenticate, Intel Core vPro are registered trademarks of Intel Corporation in the United States and other countries.

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAADFEFNKEFF
Date   Source Headline
24th Oct 20237:00 amRNSNotice of Interim Results & Investor Presentation
20th Oct 20237:03 amRNSAppointment of Non-Executive Director
11th Oct 20237:00 amRNSDirector/PDMR Shareholding
10th Oct 20237:00 amRNSTrading Update
21st Sep 20231:31 pmRNSResult of AGM
4th Sep 20237:00 amRNSContract and Renewals Orders
30th Aug 20237:10 amRNSNotice of AGM and Publication of Annual Report
20th Jun 20237:01 amRNSBoard Changes
20th Jun 20237:00 amRNSFinal Results
12th Jun 20237:00 amRNSNotice of Results & Investor Presentation
27th Apr 20237:00 amRNSShare Incentive Plan
17th Apr 20237:00 amRNSTrading Update
3rd Apr 20237:00 amRNSContract wins/renewals
3rd Feb 202310:46 amRNSDirector/PDMR Shareholding
31st Jan 20237:00 amRNSChange of Auditors
23rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
23rd Jan 20234:35 pmRNSPrice Monitoring Extension
23rd Jan 20232:05 pmRNSSecond Price Monitoring Extn
23rd Jan 20232:00 pmRNSPrice Monitoring Extension
23rd Jan 20237:00 amRNSTrading Update
11th Jan 20232:30 pmRNSDirector/PDMR Shareholding
2nd Dec 20228:45 amRNSDirector/PDMR Shareholding
22nd Nov 20227:00 amRNSHalf-year Report
11th Nov 20227:00 amRNSNotice of Interim Results & Investor Presentation
13th Oct 202210:30 amRNSDirector/PDMR Shareholding
11th Oct 20221:00 pmRNSDirector/PDMR Shareholding
10th Oct 20228:00 amRNSLong Term Incentive Plan
10th Oct 20227:01 amRNSAcquisition of Authlogics Ltd
10th Oct 20227:00 amRNSTrading Update
28th Sep 202212:22 pmRNSResult of AGM
15th Sep 20227:00 amRNSDirector/PDMR Shareholding and Issue of Equity
10th Aug 20227:00 amRNSNotice of AGM
30th Jun 20227:00 amRNSBoard Changes
8th Jun 20227:00 amRNSFinal Results
25th May 202210:15 amRNSInvestor Presentation
12th Apr 20227:00 amRNSAppointment of CFO
6th Apr 20227:00 amRNSDirector/PDMR Shareholding
5th Apr 20227:00 amRNSTrading Update & Contract Win
30th Mar 202210:01 amRNSReceipt of $3.4m Order
2nd Feb 20227:00 amRNSContract Win
8th Dec 20213:55 pmRNSDirector/PDMR Shareholding and Issue of Equity
23rd Nov 20217:00 amRNSHalf-year Report
19th Nov 20217:00 amRNSHolding(s) in Company-Amendment
17th Nov 20217:00 amRNSInvestor Presentation
16th Nov 20217:00 amRNSHolding(s) in Company
15th Nov 20213:45 pmRNSTotal Voting Rights
11th Nov 20214:12 pmRNSHolding(s) in Company
11th Oct 20217:00 amRNSTrading Update
15th Sep 20212:09 pmRNSResult of AGM
15th Sep 20217:00 amRNSMultiple Customers choose to Upgrade MyID

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.